Ireland vs Papua New Guinea: Prevalence rate of obesity in adults
Ireland
27.9%
in 2024
Papua New Guinea
28.0%
in 2024
Ireland rank
75th
Papua New Guinea rank
73rd
Prevalence rate of obesity in adults over time
- Ireland
- Papua New Guinea
How they compare
Papua New Guinea currently reports 28.0% against 27.9% in Ireland, a difference of 0.1%.
The two have swapped places 2 times across 45 shared years of data; in 1980 it was Papua New Guinea ahead.
Ireland ranks 75th and Papua New Guinea ranks 73rd of 199 countries.
Across the 5 decades both report, Ireland averaged higher in 4 and Papua New Guinea in 1.
Head to head by decade
| Decade | Ireland | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 10.8% | 11.6% | 0.8% | Papua New Guinea |
| 1990s | 15.8% | 15.4% | 0.4% | Ireland |
| 2000s | 21.7% | 19.6% | 2.1% | Ireland |
| 2010s | 25.5% | 23.6% | 1.9% | Ireland |
| 2020s | 27.4% | 27.0% | 0.4% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of obesity in adults, Ireland or Papua New Guinea?
- Papua New Guinea, at 28.0% against 27.9% in Ireland as of 2024.
- What is the difference in prevalence rate of obesity in adults between Ireland and Papua New Guinea?
- 0.1%, with Papua New Guinea ahead.
- How many years of comparable data are there for Ireland and Papua New Guinea?
- 45 years are reported by both, from 1980 to 2024.
- How do Ireland and Papua New Guinea rank globally for prevalence rate of obesity in adults?
- Ireland ranks 75th and Papua New Guinea ranks 73rd of 199 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) β with minor processing by Our World in Data, published as Prevalence rate of obesity in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated prevalence of obesity in adults, based on general population surveys and statistical modeling. Obesity is a risk factor for chronic complications, including cardiovascular disease, and premature death.